KDNY — Chinook Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapMomentum Trap

Annual balance sheet for Chinook Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	266	214	247	287	378
Net Total Accounts Receivable
Net Total Receivables	12	0.342	0.262	10.1	1.09
Prepaid Expenses
Total Other Current Assets
Total Current Assets	283	218	254	301	386
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	29.2	45.8	76.3	74.3	65.9
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	358	291	429	564	574
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	30.5	21.6	22.8	40.1	50.8
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	222	226	94.4	110	132
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	135	65.6	335	454	442
Total Liabilities & Shareholders' Equity	358	291	429	564	574
Total Common Shares Outstanding
Total Preferred Shares Outstanding